Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma

Daniela Spallarossa, Elena Battistini, Michela Silvestri, Federica Sabatini, Maurizio G. Biraghi, Giovanni A. Rossi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Exhaled nitric oxide levels are elevated in asthmatic children and decrease after inhaled steroid treatment. We evaluated the time-dependent changes in fractional exhaled nitric oxide concentration (FENO) and pulmonary function parameters following inhaled steroid therapy. Thirty-nine steroid-naive atopic patients (age 11.92 ± 0.48 years) with mild intermittent asthma and 22 age-matched healthy controls were enrolled in the study; pulmonary functions and FENO levels were measured. Low doses of inhaled steroids were prescribed to all asthmatic patients who were reevaluated in a second visit (between 10 and 40 days after the beginning of the treatment). At the enrolment, asthmatic patients had similar forced expiratory volume in 1 sec (FEV1) and forced vital capacity (FVC) values (p > 0.05) but reduced forced expiratory flows at 25-75% of the vital capacity (FEF25-75%) values, as compared to controls (p <0.05). In addition, FENO levels were significantly higher in asthmatics with respect to control subjects (30.8±3.0 and 4.0±0.5 ppb, respectively; p <0.01). All asthmatics had FENO levels higher than 8.8 ppb (i.e., > 2 standard deviations of the mean in controls). After steroid treatment, patients showed significant improvement of FEV1, FVC, and FEF25-75% (p =0.0001; each comparison) and a reduction of FENO levels (p=0.0001). A weak significant correlation was found between percent decrease in FENO levels and percent increase in FEV1 (r=0.33, p=0.04) or in FEF25-75% (r=0.4, p = 0.01) after treatment. When changes in FENO levels and in pulmonary function parameters were corrected for days of treatment, significant correlations were still present between percent decrease in FENO levels and percent increase in FEV1 (r=0.57, p= 0.0004) or percent increase in FEF25-75% (r=0.45, p=0.006). Sixteen of the 39 asthmatic patients were evaluated on two occasions after the beginning of treatment, at days 10 and 40. The significant reduction in FENO levels (p <0.01) and the significant increase in FEV1 and FEF25-75% values observed (p <0.05) after 10 days did not further improve at day 40. These data show that it is possible to demonstrate early effects of low-dose inhaled steroids in asthmatic children using objective measurements of airway caliber and inflammation.

Original languageEnglish
Pages (from-to)545-553
Number of pages9
JournalJournal of Asthma
Volume38
Issue number7
DOIs
Publication statusPublished - 2001

Fingerprint

Vital Capacity
Adrenal Cortex Hormones
Nitric Oxide
Asthma
Forced Expiratory Volume
Lung
Steroids
Therapeutics
Inflammation

Keywords

  • Airflow limitation
  • Airway inflammation
  • Corticosteroids

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma. / Spallarossa, Daniela; Battistini, Elena; Silvestri, Michela; Sabatini, Federica; Biraghi, Maurizio G.; Rossi, Giovanni A.

In: Journal of Asthma, Vol. 38, No. 7, 2001, p. 545-553.

Research output: Contribution to journalArticle

Spallarossa, Daniela ; Battistini, Elena ; Silvestri, Michela ; Sabatini, Federica ; Biraghi, Maurizio G. ; Rossi, Giovanni A. / Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma. In: Journal of Asthma. 2001 ; Vol. 38, No. 7. pp. 545-553.
@article{880eabb27e304d4b9cb2530c44e2e648,
title = "Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma",
abstract = "Exhaled nitric oxide levels are elevated in asthmatic children and decrease after inhaled steroid treatment. We evaluated the time-dependent changes in fractional exhaled nitric oxide concentration (FENO) and pulmonary function parameters following inhaled steroid therapy. Thirty-nine steroid-naive atopic patients (age 11.92 ± 0.48 years) with mild intermittent asthma and 22 age-matched healthy controls were enrolled in the study; pulmonary functions and FENO levels were measured. Low doses of inhaled steroids were prescribed to all asthmatic patients who were reevaluated in a second visit (between 10 and 40 days after the beginning of the treatment). At the enrolment, asthmatic patients had similar forced expiratory volume in 1 sec (FEV1) and forced vital capacity (FVC) values (p > 0.05) but reduced forced expiratory flows at 25-75{\%} of the vital capacity (FEF25-75{\%}) values, as compared to controls (p <0.05). In addition, FENO levels were significantly higher in asthmatics with respect to control subjects (30.8±3.0 and 4.0±0.5 ppb, respectively; p <0.01). All asthmatics had FENO levels higher than 8.8 ppb (i.e., > 2 standard deviations of the mean in controls). After steroid treatment, patients showed significant improvement of FEV1, FVC, and FEF25-75{\%} (p =0.0001; each comparison) and a reduction of FENO levels (p=0.0001). A weak significant correlation was found between percent decrease in FENO levels and percent increase in FEV1 (r=0.33, p=0.04) or in FEF25-75{\%} (r=0.4, p = 0.01) after treatment. When changes in FENO levels and in pulmonary function parameters were corrected for days of treatment, significant correlations were still present between percent decrease in FENO levels and percent increase in FEV1 (r=0.57, p= 0.0004) or percent increase in FEF25-75{\%} (r=0.45, p=0.006). Sixteen of the 39 asthmatic patients were evaluated on two occasions after the beginning of treatment, at days 10 and 40. The significant reduction in FENO levels (p <0.01) and the significant increase in FEV1 and FEF25-75{\%} values observed (p <0.05) after 10 days did not further improve at day 40. These data show that it is possible to demonstrate early effects of low-dose inhaled steroids in asthmatic children using objective measurements of airway caliber and inflammation.",
keywords = "Airflow limitation, Airway inflammation, Corticosteroids",
author = "Daniela Spallarossa and Elena Battistini and Michela Silvestri and Federica Sabatini and Biraghi, {Maurizio G.} and Rossi, {Giovanni A.}",
year = "2001",
doi = "10.1081/JAS-100107119",
language = "English",
volume = "38",
pages = "545--553",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma

AU - Spallarossa, Daniela

AU - Battistini, Elena

AU - Silvestri, Michela

AU - Sabatini, Federica

AU - Biraghi, Maurizio G.

AU - Rossi, Giovanni A.

PY - 2001

Y1 - 2001

N2 - Exhaled nitric oxide levels are elevated in asthmatic children and decrease after inhaled steroid treatment. We evaluated the time-dependent changes in fractional exhaled nitric oxide concentration (FENO) and pulmonary function parameters following inhaled steroid therapy. Thirty-nine steroid-naive atopic patients (age 11.92 ± 0.48 years) with mild intermittent asthma and 22 age-matched healthy controls were enrolled in the study; pulmonary functions and FENO levels were measured. Low doses of inhaled steroids were prescribed to all asthmatic patients who were reevaluated in a second visit (between 10 and 40 days after the beginning of the treatment). At the enrolment, asthmatic patients had similar forced expiratory volume in 1 sec (FEV1) and forced vital capacity (FVC) values (p > 0.05) but reduced forced expiratory flows at 25-75% of the vital capacity (FEF25-75%) values, as compared to controls (p <0.05). In addition, FENO levels were significantly higher in asthmatics with respect to control subjects (30.8±3.0 and 4.0±0.5 ppb, respectively; p <0.01). All asthmatics had FENO levels higher than 8.8 ppb (i.e., > 2 standard deviations of the mean in controls). After steroid treatment, patients showed significant improvement of FEV1, FVC, and FEF25-75% (p =0.0001; each comparison) and a reduction of FENO levels (p=0.0001). A weak significant correlation was found between percent decrease in FENO levels and percent increase in FEV1 (r=0.33, p=0.04) or in FEF25-75% (r=0.4, p = 0.01) after treatment. When changes in FENO levels and in pulmonary function parameters were corrected for days of treatment, significant correlations were still present between percent decrease in FENO levels and percent increase in FEV1 (r=0.57, p= 0.0004) or percent increase in FEF25-75% (r=0.45, p=0.006). Sixteen of the 39 asthmatic patients were evaluated on two occasions after the beginning of treatment, at days 10 and 40. The significant reduction in FENO levels (p <0.01) and the significant increase in FEV1 and FEF25-75% values observed (p <0.05) after 10 days did not further improve at day 40. These data show that it is possible to demonstrate early effects of low-dose inhaled steroids in asthmatic children using objective measurements of airway caliber and inflammation.

AB - Exhaled nitric oxide levels are elevated in asthmatic children and decrease after inhaled steroid treatment. We evaluated the time-dependent changes in fractional exhaled nitric oxide concentration (FENO) and pulmonary function parameters following inhaled steroid therapy. Thirty-nine steroid-naive atopic patients (age 11.92 ± 0.48 years) with mild intermittent asthma and 22 age-matched healthy controls were enrolled in the study; pulmonary functions and FENO levels were measured. Low doses of inhaled steroids were prescribed to all asthmatic patients who were reevaluated in a second visit (between 10 and 40 days after the beginning of the treatment). At the enrolment, asthmatic patients had similar forced expiratory volume in 1 sec (FEV1) and forced vital capacity (FVC) values (p > 0.05) but reduced forced expiratory flows at 25-75% of the vital capacity (FEF25-75%) values, as compared to controls (p <0.05). In addition, FENO levels were significantly higher in asthmatics with respect to control subjects (30.8±3.0 and 4.0±0.5 ppb, respectively; p <0.01). All asthmatics had FENO levels higher than 8.8 ppb (i.e., > 2 standard deviations of the mean in controls). After steroid treatment, patients showed significant improvement of FEV1, FVC, and FEF25-75% (p =0.0001; each comparison) and a reduction of FENO levels (p=0.0001). A weak significant correlation was found between percent decrease in FENO levels and percent increase in FEV1 (r=0.33, p=0.04) or in FEF25-75% (r=0.4, p = 0.01) after treatment. When changes in FENO levels and in pulmonary function parameters were corrected for days of treatment, significant correlations were still present between percent decrease in FENO levels and percent increase in FEV1 (r=0.57, p= 0.0004) or percent increase in FEF25-75% (r=0.45, p=0.006). Sixteen of the 39 asthmatic patients were evaluated on two occasions after the beginning of treatment, at days 10 and 40. The significant reduction in FENO levels (p <0.01) and the significant increase in FEV1 and FEF25-75% values observed (p <0.05) after 10 days did not further improve at day 40. These data show that it is possible to demonstrate early effects of low-dose inhaled steroids in asthmatic children using objective measurements of airway caliber and inflammation.

KW - Airflow limitation

KW - Airway inflammation

KW - Corticosteroids

UR - http://www.scopus.com/inward/record.url?scp=0035168130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035168130&partnerID=8YFLogxK

U2 - 10.1081/JAS-100107119

DO - 10.1081/JAS-100107119

M3 - Article

C2 - 11714077

AN - SCOPUS:0035168130

VL - 38

SP - 545

EP - 553

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 7

ER -